SGLT2 inhibitor: 2-way superstar in nephrology?

Kidney Int. 2024 Jun;105(6):1176-1177. doi: 10.1016/j.kint.2024.03.017.
No abstract available

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetic Nephropathies / drug therapy
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Nephrology
  • Sodium-Glucose Transporter 2 / metabolism
  • Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

  • Sodium-Glucose Transporter 2 Inhibitors
  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2
  • SLC5A2 protein, human